Comparison of the early clinical efficacy of the SuperPath approach versus the modified Hardinge approach in total hip arthroplasty for femoral neck fractures in elderly patients: a randomized controlled trial

Table 3 Perioperative serum markers change in two groups (Mean ± SD)

Parameters	Timings	SuperPath group (n = 57)	Conventional group (n = 56)	p Value
CRP (mg/l)	Pre	7.39 ± 6.55	7.16 ± 6.27	0.848
	1 d	62.72 ± 25.83	64.10 ± 21.27	0.757
	3 d	62.34 ± 20.58	58.31 ± 26.81	0.371
	7 d	14.45 ± 9.63	16.33 ± 10.51	0.323
ESR (mm/h)	Pre	18.04 ± 5.75	17.68 ± 4.94	0.725
	1 d	29.60 ± 6.72	27.63 ± 6.61	0.119
	3 d	50.16 ± 14.61	52.18 ± 15.07	0.471
	7 d	29.19 ± 10.06	30.52 ± 10.45	0.494
CK (u/l)	Pre	80.70 ± 43.90	84.70 ± 49.30	0.650
	1 d	279.58 ± 88.67	609.71 ± 111.31	0.000*
	3 d	168.54 ± 85.61	314.02 ± 123.19	0.000*
	7 d	89.95 ± 50.90	119.14 ± 59.27	0.006*

*p < 0.05 indicate significant differences from the conventional. CRP C-reactive protein, ESR erythrocyte sedimentation rate, CK creatine kinase

ISSN: 1749-799X